In what is simultaneously a nice slice of good news and awful news, the minds behind Netflix's riveting Making a Murderer docuseries have announced details of their next project, a project that has absolutely nothing to do with Steven Avery. Making a Murderer directors Laura Ricciardi and Moira Demos are working on an adaptation of the serialized Huffington Post article "America's Most Admired Lawbreaker," according to Paste.
Steven Brill penned the 2015 article, which centers on how Johnson & Johnson made billions from the controversial Risperdal drug. After the public became privy to the drug's harmful side effects, a $2 billion settlement was reached. But given that the company had already raked in roughly $30 billion while withholding information about the side effects, many argued that justice was never truly served.
Lawbreaker is getting assistance from Smokehouse Pictures, a production company co-founded by some guy named George Clooney back in 2006 following the dissolution of his Section Eight empire earlier in the year. Ricciardi and Demos will once again co-direct the adaptation, following their acclaimed work on Making a Murderer.
The concept of injustice should strike a familiar chord for those who obsessively binged Making a Murderer. The series, which kicked off a national discussion on both Steven Avery's murder conviction and the criminal justice system at large, proved a massive success for Netflix. In the months since its debut, whisperings of a second season have grown to a full-on roar. Back in February, Ricciardi told Variety they're still following Avery's story closely.
"From our perspective this story is obviously not over," Ricciardi said. "It's real life and (Avery's and Brendan Dassey's) cases are both still pending. We have no idea when the magistrate will make a decision in Brendan's case. We do know that two potential outcomes are that the judge could order Brendan's release or he could order a new trial. So we are on the edge of our seats about that."